TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/1/23 17:35 | 4/28/23 | MRNA | Moderna, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Horning Sandra | MA | D | M.d | 0 | 0.00 | 0 | 1 | 95 | 1 | D | |||||||||||||||
5/3/22 20:15 | 5/3/22 | GILD | Gilead Sciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Horning Sandra | CA | D | M.d | 0 | 0.00 | 0 | 1 | 176 | 2 | D | |||||||||||||||
5/2/22 16:38 | 4/28/22 | MRNA | Moderna, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Horning Sandra | MA | D | M.d | 0 | 0.00 | 0 | 1 | New | 1 | D | |||||||||||||||
1/29/21 17:46 | 1/28/21 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Horning Sandra | CA | D | M.d | 0 | 0.00 | 0 | 1 | New | 1 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |